(Q43218078)

16 November 2017

Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase (English)

1 reference

16 November 2017

17

Nathanael S Gray

1 reference

16 November 2017

Wooyoung Hur

1

1 reference

16 November 2017

Anastasia Velentza

2

1 reference

16 November 2017

Sungjoon Kim

3

1 reference

16 November 2017

Laura Flatauer

4

1 reference

16 November 2017

Xinnong Jiang

5

1 reference

16 November 2017

David Valente

6

1 reference

16 November 2017

Daniel E Mason

7

1 reference

16 November 2017

Melissa Suzuki

8

1 reference

16 November 2017

Brad Larson

9

1 reference

16 November 2017

Jianming Zhang

10

1 reference

16 November 2017

Anna Zagorska

11

1 reference

16 November 2017

Michael Didonato

12

1 reference

16 November 2017

Advait Nagle

13

1 reference

16 November 2017

Markus Warmuth

14

1 reference

16 November 2017

Steven P Balk

15

1 reference

16 November 2017

Eric C Peters

16

1 reference

16 November 2017

language of work or name

English

0 references

publication date

18 July 2008

1 reference

Bioorganic & Medicinal Chemistry Letters

16 November 2017

1 reference

16 November 2017

18

1 reference

16 November 2017

22

1 reference

16 November 2017

5916-5919

1 reference

Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells

16 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Epidermal growth factor receptor mutations in lung cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

An efficient rapid system for profiling the cellular activities of molecular libraries.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Structural bioinformatics-based design of selective, irreversible kinase inhibitors

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2610413

10.1016/J.BMCL.2008.07.062

25 May 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

18667312

1 reference